Already we have published a number of articles in peer reviewed journals outlining our approach to discovering and developing optimized ASO medicines for nano-rare patients. Our library of publications will continue to grow as we publish peer reviewed manuscripts and support our treating physicians for their case reports.
We have made hundreds of presentations, including at scientific meetings, patient advocacy forums, internal employee presentations for our partners, expert panelist opportunities and other personalized medicine summits. In some presentations, we have provided a step-by-step detailed road map illustrating how we identify an optimal ASO. This road map includes the number of ASOs screened, and the number of ASOs studied at each step, the analytes measured and our stringent criteria for advancing an ASO at each step. Our goal is to educate the community to ensure that only the best ASOs reach nano-rare patients.